FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
John Souglakos(University Hospital of Heraklion), Vassilis Georgoulias(University Hospital of Heraklion)
Cited by 402
Related Papers
No related papers found
Powered by citation graph analysis